Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study

Clinical trial NCT02623062 · COMPLETED

Trial details

NCT number: NCT02623062
Sponsor: Reckitt Benckiser Healthcare (UK) Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastro-esophageal Reflux Disease (GERD)

Start date: 2013-12-01
Primary completion: 2016-03-01
Enrollment: 644

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.